While imaging remains the cornerstone of HCC detection, biomarkers like AFP add diagnostic value, especially in cases where imaging results are inconclusive or in high-risk patients such as those with chronic hepatitis B or cirrhosis. Here, AFP is linked to hepatocellular carcinoma.